| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |